EUVIMEDEUVIMED entdecken
Querschnittstudie

Interleukin-17 potentially links prolactin to positive symptoms in first-episode drug-naive schizophrenia: An exploratory cross-sectional study

Wenxi Liu, Xiaowei Xia, Zilin Hong, Zixin Deng, Fu Zhu, Kexin Zhang, Shimao Kang, Qinling Wei, Jiong Tao, Leijun Li

Schizophrenia Research · 2026

DOI: 10.1016/j.schres.2026.09.031 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Schizophrenia Research, 2026. Verfasst von Wenxi Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Prolactin, Schizophrenia, Interleukin-17. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Guangdong Provincial Natural Science Foundation, Guangzhou Municipal Science and Technology Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immune-inflammation hypothesis of schizophrenia has gained considerable support, yet the role of endocrine-immune interplay remains unclear. Prolactin, a stress-responsive hormone with immunomodulatory properties, is elevated in first-episode drug-naive (FEDN) schizophrenia independently of antipsychotic exposure. We hypothesized that increased prolactin may contribute to symptom severity and cognitive dysfunction by modulating specific inflammatory cytokines, with potential implications for schizophrenia pathophysiology. This study examined prolactin and inflammatory cytokines in 50 FEDN schizophrenia patients and 52 healthy controls (HCs), and evaluated both between-group differences and within-patient associations with clinical features. Patients exhibited elevated prolactin levels and altered inflammatory profiles, including increased IFN-γ and relatively lower IL-8 and IL-12p70 levels. Although IL-17 was numerically lower in patients in the crude comparison, this between-group difference was attenuated after covariate adjustment. Within the patient group, lower IL-17 levels were nominally associated with higher prolactin levels and more severe positive symptoms. Mediation identified a significant indirect effect involving IL-17 in the association between prolactin and positive symptoms, indicating its possible involvement in linking endocrine dysregulation to symptom severity. These exploratory findings suggest that IL-17 may be relevant to within-patient symptom-related processes, and provide preliminary evidence for endocrine-immune interactions in schizophrenia that warrant replication in larger samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProlactinSchizophreniaInterleukin-17HumansFemaleMaleAdultCross-Sectional StudiesYoung Adult

Stichwörter der Autor:innen

Immune dysregulationInterleukin-17Positive symptomsProlactinSchizophrenia

Substanzen

ProlactinInterleukin-17

Autor:innen und Institutionen

  • Department of Psychiatry, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Department of Psychiatry, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Electronic address: taojiong@mail.sysu.edu.cn.
  • Department of Psychiatry, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Electronic address: lileijun@mail.sysu.edu.cn.

Förderung

  • Guangdong Provincial Natural Science Foundation
  • Guangzhou Municipal Science and Technology Project
  • National Natural Science Foundation of China

Zitieren

APA

Liu, W., Xia, X., Hong, Z., Deng, Z., Zhu, F., Zhang, K., Kang, S., Wei, Q., Tao, J., & Li, L. (2026). Interleukin-17 potentially links prolactin to positive symptoms in first-episode drug-naive schizophrenia: An exploratory cross-sectional study. Schizophrenia Research. https://doi.org/10.1016/j.schres.2026.09.031

Vancouver

Liu W, Xia X, Hong Z, Deng Z, Zhu F, Zhang K, et al. Interleukin-17 potentially links prolactin to positive symptoms in first-episode drug-naive schizophrenia: An exploratory cross-sectional study. Schizophrenia Research. 2026. doi:10.1016/j.schres.2026.09.031

BibTeX
@article{Liu2026,
  author = {Liu, Wenxi and Xia, Xiaowei and Hong, Zilin and Deng, Zixin and Zhu, Fu and Zhang, Kexin and Kang, Shimao and Wei, Qinling and Tao, Jiong and Li, Leijun},
  title = {Interleukin-17 potentially links prolactin to positive symptoms in first-episode drug-naive schizophrenia: An exploratory cross-sectional study},
  journal = {Schizophrenia Research},
  year = {2026},
  doi = {10.1016/j.schres.2026.09.031}
}
Kostenlos starten →